News EpiWatch app detects major seizures with few false alarms An Apple Watch patient monitoring app can help people with epilepsy reduce the risk of sudden death, with high sensitivity and a low false alarm rate.
News FDA clears first at-home device for depression Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.
News Wearable alert system for epileptics set for European launch An AI-powered wearable device that warns people with epilepsy about an impending seizure will launch in Europe next year.
News Biolinq bags FDA okay for autonomous glucose sensor Biolinq gets an FDA green light for its autonomous, needle-free continuous glucose monitor, plus a roundup of other medtech developments.
News Apple Watch hypertension feature cleared by FDA The latest Apple Watch will include a just-approved health feature that will warn users if they show signs of chronic hypertension.
News Ametris starts obesity digital endpoint project with pharma Ametris launches a collaboration with pharma companies that aims to show how digital endpoints can be used in obesity trials.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.